IBDEI01L ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1677,1,5,0)
 ;;=5^174.4
 ;;^UTILITY(U,$J,358.3,1677,2)
 ;;=Cancer, Upper Outer Breast^267198
 ;;^UTILITY(U,$J,358.3,1678,0)
 ;;=610.0^^21^144^13
 ;;^UTILITY(U,$J,358.3,1678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1678,1,4,0)
 ;;=4^Cyst,Breast
 ;;^UTILITY(U,$J,358.3,1678,1,5,0)
 ;;=5^610.0
 ;;^UTILITY(U,$J,358.3,1678,2)
 ;;=^112247
 ;;^UTILITY(U,$J,358.3,1679,0)
 ;;=625.3^^21^144^14
 ;;^UTILITY(U,$J,358.3,1679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1679,1,4,0)
 ;;=4^Dysmenorrhea
 ;;^UTILITY(U,$J,358.3,1679,1,5,0)
 ;;=5^625.3
 ;;^UTILITY(U,$J,358.3,1679,2)
 ;;=^37592
 ;;^UTILITY(U,$J,358.3,1680,0)
 ;;=610.1^^21^144^18
 ;;^UTILITY(U,$J,358.3,1680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1680,1,4,0)
 ;;=4^Fibrocystic Disease,Breast
 ;;^UTILITY(U,$J,358.3,1680,1,5,0)
 ;;=5^610.1
 ;;^UTILITY(U,$J,358.3,1680,2)
 ;;=^46167
 ;;^UTILITY(U,$J,358.3,1681,0)
 ;;=217.^^21^144^2
 ;;^UTILITY(U,$J,358.3,1681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1681,1,4,0)
 ;;=4^Benign Neoplasm Breast
 ;;^UTILITY(U,$J,358.3,1681,1,5,0)
 ;;=5^217.
 ;;^UTILITY(U,$J,358.3,1681,2)
 ;;=^267638
 ;;^UTILITY(U,$J,358.3,1682,0)
 ;;=617.9^^21^144^15
 ;;^UTILITY(U,$J,358.3,1682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1682,1,4,0)
 ;;=4^Endometriosis
 ;;^UTILITY(U,$J,358.3,1682,1,5,0)
 ;;=5^617.9
 ;;^UTILITY(U,$J,358.3,1682,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,1683,0)
 ;;=618.6^^21^144^16
 ;;^UTILITY(U,$J,358.3,1683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1683,1,4,0)
 ;;=4^Enterocele,Vaginal
 ;;^UTILITY(U,$J,358.3,1683,1,5,0)
 ;;=5^618.6
 ;;^UTILITY(U,$J,358.3,1683,2)
 ;;=^56796
 ;;^UTILITY(U,$J,358.3,1684,0)
 ;;=625.6^^21^144^20
 ;;^UTILITY(U,$J,358.3,1684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1684,1,4,0)
 ;;=4^Incontin,Female Stress
 ;;^UTILITY(U,$J,358.3,1684,1,5,0)
 ;;=5^625.6
 ;;^UTILITY(U,$J,358.3,1684,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,1685,0)
 ;;=611.72^^21^144^21
 ;;^UTILITY(U,$J,358.3,1685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1685,1,4,0)
 ;;=4^Lump/Mass In Breast
 ;;^UTILITY(U,$J,358.3,1685,1,5,0)
 ;;=5^611.72
 ;;^UTILITY(U,$J,358.3,1685,2)
 ;;=Lump/Mass in Breast^72018
 ;;^UTILITY(U,$J,358.3,1686,0)
 ;;=795.00^^21^144^1
 ;;^UTILITY(U,$J,358.3,1686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1686,1,4,0)
 ;;=4^Abnormal Pap Smear, Nos
 ;;^UTILITY(U,$J,358.3,1686,1,5,0)
 ;;=5^795.00
 ;;^UTILITY(U,$J,358.3,1686,2)
 ;;=Abnormal Pap Smear, NOS^117041
 ;;^UTILITY(U,$J,358.3,1687,0)
 ;;=618.00^^21^144^29
 ;;^UTILITY(U,$J,358.3,1687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1687,1,4,0)
 ;;=4^Vaginal Wall Prolpse Nos
 ;;^UTILITY(U,$J,358.3,1687,1,5,0)
 ;;=5^618.00
 ;;^UTILITY(U,$J,358.3,1687,2)
 ;;=^331533
 ;;^UTILITY(U,$J,358.3,1688,0)
 ;;=611.89^^21^144^19
 ;;^UTILITY(U,$J,358.3,1688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1688,1,4,0)
 ;;=4^Hematoma,Breast
 ;;^UTILITY(U,$J,358.3,1688,1,5,0)
 ;;=5^611.89
 ;;^UTILITY(U,$J,358.3,1688,2)
 ;;=^336616
 ;;^UTILITY(U,$J,358.3,1689,0)
 ;;=173.51^^21^144^10
 ;;^UTILITY(U,$J,358.3,1689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1689,1,4,0)
 ;;=4^Cancer, Skin Of Breast
 ;;^UTILITY(U,$J,358.3,1689,1,5,0)
 ;;=5^173.51
 ;;^UTILITY(U,$J,358.3,1689,2)
 ;;=^340479
 ;;^UTILITY(U,$J,358.3,1690,0)
 ;;=175.9^^21^145^1
 ;;^UTILITY(U,$J,358.3,1690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1690,1,4,0)
 ;;=4^Ca, Male Breast
 ;;^UTILITY(U,$J,358.3,1690,1,5,0)
 ;;=5^175.9
 ;;^UTILITY(U,$J,358.3,1690,2)
 ;;=CA, Male Breast^267205
 ;;^UTILITY(U,$J,358.3,1691,0)
 ;;=175.0^^21^145^2
 ;;^UTILITY(U,$J,358.3,1691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1691,1,4,0)
 ;;=4^Ca, Male Nipple
 ;;^UTILITY(U,$J,358.3,1691,1,5,0)
 ;;=5^175.0
 ;;^UTILITY(U,$J,358.3,1691,2)
 ;;=CA, Male Nipple^267204
 ;;^UTILITY(U,$J,358.3,1692,0)
 ;;=611.1^^21^145^3
 ;;^UTILITY(U,$J,358.3,1692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1692,1,4,0)
 ;;=4^Gynecomastia,Male
 ;;^UTILITY(U,$J,358.3,1692,1,5,0)
 ;;=5^611.1
 ;;^UTILITY(U,$J,358.3,1692,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,1693,0)
 ;;=216.0^^21^146^4
 ;;^UTILITY(U,$J,358.3,1693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1693,1,4,0)
 ;;=4^Benign Lesion, Lip
 ;;^UTILITY(U,$J,358.3,1693,1,5,0)
 ;;=5^216.0
 ;;^UTILITY(U,$J,358.3,1693,2)
 ;;=Benign Neoplasm of Skin of Lip^267629
 ;;^UTILITY(U,$J,358.3,1694,0)
 ;;=216.1^^21^146^2
 ;;^UTILITY(U,$J,358.3,1694,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1694,1,4,0)
 ;;=4^Benign Lesion, Eyelid
 ;;^UTILITY(U,$J,358.3,1694,1,5,0)
 ;;=5^216.1
 ;;^UTILITY(U,$J,358.3,1694,2)
 ;;=Benign Neoplasm of Skin of Eyelid^267630
 ;;^UTILITY(U,$J,358.3,1695,0)
 ;;=216.2^^21^146^1
 ;;^UTILITY(U,$J,358.3,1695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1695,1,4,0)
 ;;=4^Benign Lesion, Ear
 ;;^UTILITY(U,$J,358.3,1695,1,5,0)
 ;;=5^216.2
 ;;^UTILITY(U,$J,358.3,1695,2)
 ;;=Benign Neoplasm of Skin of Ear^267631
 ;;^UTILITY(U,$J,358.3,1696,0)
 ;;=216.4^^21^146^6
 ;;^UTILITY(U,$J,358.3,1696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1696,1,4,0)
 ;;=4^Benign Lesion, Neck
 ;;^UTILITY(U,$J,358.3,1696,1,5,0)
 ;;=5^216.4
 ;;^UTILITY(U,$J,358.3,1696,2)
 ;;=Benign Neoplasm of Skin of Neck^267633
 ;;^UTILITY(U,$J,358.3,1697,0)
 ;;=216.5^^21^146^8
 ;;^UTILITY(U,$J,358.3,1697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1697,1,4,0)
 ;;=4^Benign Lesion, Trunk
 ;;^UTILITY(U,$J,358.3,1697,1,5,0)
 ;;=5^216.5
 ;;^UTILITY(U,$J,358.3,1697,2)
 ;;=Benign Neoplasm of Skin of Trunk^267634
 ;;^UTILITY(U,$J,358.3,1698,0)
 ;;=216.6^^21^146^9
 ;;^UTILITY(U,$J,358.3,1698,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1698,1,4,0)
 ;;=4^Benign Lesion, Upper Limb
 ;;^UTILITY(U,$J,358.3,1698,1,5,0)
 ;;=5^216.6
 ;;^UTILITY(U,$J,358.3,1698,2)
 ;;=Benign Neoplasm of Skin of Arm^267635
 ;;^UTILITY(U,$J,358.3,1699,0)
 ;;=216.7^^21^146^5
 ;;^UTILITY(U,$J,358.3,1699,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1699,1,4,0)
 ;;=4^Benign Lesion, Lower Limb
 ;;^UTILITY(U,$J,358.3,1699,1,5,0)
 ;;=5^216.7
 ;;^UTILITY(U,$J,358.3,1699,2)
 ;;=Benign Neoplasm of of skin of leg^267636
 ;;^UTILITY(U,$J,358.3,1700,0)
 ;;=216.8^^21^146^7
 ;;^UTILITY(U,$J,358.3,1700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1700,1,4,0)
 ;;=4^Benign Lesion, Skin Other
 ;;^UTILITY(U,$J,358.3,1700,1,5,0)
 ;;=5^216.8
 ;;^UTILITY(U,$J,358.3,1700,2)
 ;;=Ben Neoplasm, Skin, Unspec^267637
 ;;^UTILITY(U,$J,358.3,1701,0)
 ;;=216.3^^21^146^3
 ;;^UTILITY(U,$J,358.3,1701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1701,1,4,0)
 ;;=4^Benign Lesion, Face
 ;;^UTILITY(U,$J,358.3,1701,1,5,0)
 ;;=5^216.3
 ;;^UTILITY(U,$J,358.3,1701,2)
 ;;=^267632
 ;;^UTILITY(U,$J,358.3,1702,0)
 ;;=173.00^^21^147^15
 ;;^UTILITY(U,$J,358.3,1702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1702,1,4,0)
 ;;=4^CA Skin Lip, Unspec
 ;;^UTILITY(U,$J,358.3,1702,1,5,0)
 ;;=5^173.00
 ;;^UTILITY(U,$J,358.3,1702,2)
 ;;=MALIG NEOPL SKIN LIP NOS^340596
 ;;^UTILITY(U,$J,358.3,1703,0)
 ;;=173.10^^21^147^12
 ;;^UTILITY(U,$J,358.3,1703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1703,1,4,0)
 ;;=4^CA Skin Eyelid, Unspec
 ;;^UTILITY(U,$J,358.3,1703,1,5,0)
 ;;=5^173.10
 ;;^UTILITY(U,$J,358.3,1703,2)
 ;;=MAL NEO EYELID/CANTH NOS^340597
 ;;^UTILITY(U,$J,358.3,1704,0)
 ;;=173.20^^21^147^11
 ;;^UTILITY(U,$J,358.3,1704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1704,1,4,0)
 ;;=4^CA Skin Ear, Unspec
 ;;^UTILITY(U,$J,358.3,1704,1,5,0)
 ;;=5^173.20
 ;;^UTILITY(U,$J,358.3,1704,2)
 ;;=MALIG NEO SKIN EAR NOS^340598
 ;;^UTILITY(U,$J,358.3,1705,0)
 ;;=173.30^^21^147^13
 ;;^UTILITY(U,$J,358.3,1705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1705,1,4,0)
 ;;=4^CA Skin Face, Unspec
 ;;^UTILITY(U,$J,358.3,1705,1,5,0)
 ;;=5^173.30
 ;;^UTILITY(U,$J,358.3,1705,2)
 ;;=MAL NEO SKN FACE NEC/NOS^340599
 ;;^UTILITY(U,$J,358.3,1706,0)
 ;;=173.40^^21^147^16
 ;;^UTILITY(U,$J,358.3,1706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1706,1,4,0)
 ;;=4^CA Skin Scalp/Neck, Unspec
 ;;^UTILITY(U,$J,358.3,1706,1,5,0)
 ;;=5^173.40
 ;;^UTILITY(U,$J,358.3,1706,2)
 ;;=MAL NEO SCLP/SKN NCK NOS^340600
 ;;^UTILITY(U,$J,358.3,1707,0)
 ;;=173.50^^21^147^17
 ;;^UTILITY(U,$J,358.3,1707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1707,1,4,0)
 ;;=4^CA Skin Trunk, Unspec
 ;;^UTILITY(U,$J,358.3,1707,1,5,0)
 ;;=5^173.50
 ;;^UTILITY(U,$J,358.3,1707,2)
 ;;=MALIG NEO SKIN TRUNK NOS^340601
 ;;^UTILITY(U,$J,358.3,1708,0)
 ;;=173.60^^21^147^10
 ;;^UTILITY(U,$J,358.3,1708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1708,1,4,0)
 ;;=4^CA Skin Arm/Shoulder, Unspec
 ;;^UTILITY(U,$J,358.3,1708,1,5,0)
 ;;=5^173.60
 ;;^UTILITY(U,$J,358.3,1708,2)
 ;;=MAL NEO SKIN UP LIMB NOS^340602
 ;;^UTILITY(U,$J,358.3,1709,0)
 ;;=173.70^^21^147^14
 ;;^UTILITY(U,$J,358.3,1709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1709,1,4,0)
 ;;=4^CA Skin Leg/Hip, Unspec
 ;;^UTILITY(U,$J,358.3,1709,1,5,0)
 ;;=5^173.70
 ;;^UTILITY(U,$J,358.3,1709,2)
 ;;=MAL NEO SKN LOW LIMB NOS^340603
 ;;^UTILITY(U,$J,358.3,1710,0)
 ;;=173.80^^21^147^18
 ;;^UTILITY(U,$J,358.3,1710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1710,1,4,0)
 ;;=4^CA Skin, Other Part
 ;;^UTILITY(U,$J,358.3,1710,1,5,0)
 ;;=5^173.80
 ;;^UTILITY(U,$J,358.3,1710,2)
 ;;=MAL NEO SKN SITE NEC/NOS^340604
 ;;^UTILITY(U,$J,358.3,1711,0)
 ;;=173.01^^21^147^6
 ;;^UTILITY(U,$J,358.3,1711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1711,1,4,0)
 ;;=4^BCC Skin,Lip
 ;;^UTILITY(U,$J,358.3,1711,1,5,0)
 ;;=5^173.01
 ;;^UTILITY(U,$J,358.3,1711,2)
 ;;=^340464
 ;;^UTILITY(U,$J,358.3,1712,0)
 ;;=173.02^^21^147^24
 ;;^UTILITY(U,$J,358.3,1712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1712,1,4,0)
 ;;=4^SCC Skin,Lip
 ;;^UTILITY(U,$J,358.3,1712,1,5,0)
 ;;=5^173.02
 ;;^UTILITY(U,$J,358.3,1712,2)
 ;;=^340465
 ;;^UTILITY(U,$J,358.3,1713,0)
 ;;=173.11^^21^147^3
 ;;^UTILITY(U,$J,358.3,1713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1713,1,4,0)
 ;;=4^BCC Skin,Eyelid
 ;;^UTILITY(U,$J,358.3,1713,1,5,0)
 ;;=5^173.11
 ;;^UTILITY(U,$J,358.3,1713,2)
 ;;=^340467
